Leveraging Genomic Factors to Improve Benefit-Risk-Reference-Cited by-同舟云学术

Leveraging Genomic Factors to Improve Benefit-Risk

Published:2017-02-03 Issue:2 Volume:10 Page:78-83
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical And Translational Science

Author:

Schuck RN¹,Charlab R¹,Blumenthal GM¹

Affiliation:

1. U.S. Food and Drug Administration; Center for Drug Evaluation and Research; Silver Spring Maryland USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cts.12439/fullpdf

Reference42 articles.

1. The role of adme pharmacogenomics in early clinical trials: Perspective of the industry pharmacogenomics working group (i-pwg);Tremaine;Pharmacogenomics,2015

2. Realities and expectations of pharmacogenomics and personalized medicine: Impact of translating genetic knowledge into clinical practice;Squassina;Pharmacogenomics,2010

3. FDA-NIH Biomarker Working Group BEST (Biomarkers, EndpointS, and other Tools) Resource (Internet). Silver Spring (MD): Food and Drug Administration (US); 2016-. Glossary 2016 https://www.ncbi.nlm.nih.gov/books/NBK338448/

4. Pharmacogenomics in the assessment of therapeutic risks versus benefits: Inside the United States Food and Drug Administration;Zineh;Pharmacotherapy,2011

5. Next-generation medicines: Past regulatory experience and considerations for the future;Pacanowski;Clin. Pharmacol. Ther,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in drug development;Atkinson's Principles of Clinical Pharmacology;2022

2. Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration–Approved Drugs;Clinical and Translational Science;2019-03-12

3. Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease;Clinical Pharmacology & Therapeutics;2018-02-23

4. Translating Precision;Clinical and Translational Science;2017-02-13